Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype

References

• Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918–22
   PubMed Web of Science ®Google Scholar
• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–9
   PubMed Web of Science ®Google Scholar
• Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510–3
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Garewel H, Kuebeler M, Sampliner RE. Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of VA Health Care System. Clin Gastroenterol Hepatol 2004; 2: 296–300
   PubMed Web of Science ®Google Scholar
• Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37: 137–43
   PubMed Web of Science ®Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212–5
   PubMed Web of Science ®Google Scholar
• Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997; 92: 2012–6
   PubMed Web of Science ®Google Scholar
• Amano Y, Komazawa Y, Ishimura N, Ohara S, Aimi M, Fujishiro H, et al. Two cases of superficial Barrett's cancer: crystal violet chromoendoscopy for detecting lesions. Gastrointest Endosc 2004; 59: 143–6
   PubMed Web of Science ®Google Scholar
• Azuma N, Endo T, Arimura Y, Motoya S, Itoh F, Hinoda Y, et al. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol 2000; 35: 583–92
   PubMed Web of Science ®Google Scholar
• Lee JI, Park H, Jung H-Y, Rhee PL, Song CW, Choi MG. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J Gastroenterol 2003; 38: 23–7
   PubMed Web of Science ®Google Scholar
• Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003; 38 Suppl: 25–30
   Web of Science ®Google Scholar
• Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, et al. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology 1999; 35: 517–24
   PubMed Web of Science ®Google Scholar
• Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, et al. Mucin expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 2000; 88: 856–61
   PubMed Web of Science ®Google Scholar
• Warson C, Van De Bovenkamp JH, Korteland-Van Male AM, Buller HA, Einerhand AW, Ectors NL, et al. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum Pathol 2002; 33: 660–8
   PubMed Web of Science ®Google Scholar
• Amano Y, Kushiyama Y, Ishihara S, Yuki T, Takahashi Y, Chinuki D, et al. Barrett's esophagus with predominant intestinal metaplasia correlates with superficial COX-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by NSAIDs usage. Aliment Pharmacol Ther 2004; 20: 793–802
   PubMed Web of Science ®Google Scholar
• Amano Y, Kushiyama Y, Ishihara S, Yuki T, Miyaoka Y, Yoshino N, et al. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short segment Barrett's esophagus. Am J Gastroenterol 2005; 100: 21–6
   PubMed Web of Science ®Google Scholar
• Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023–9
   PubMed Web of Science ®Google Scholar
• Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172–80
   PubMed Web of Science ®Google Scholar
• Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001; 16: 132–6
   PubMed Web of Science ®Google Scholar
• Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87–97
   Google Scholar
• Armstrong D. Review article: towards consistency in the endoscopic diagnosis of Barrett's esophagus and columnar metaplasia. Aliment Pharmacol Ther 2004; 20 Suppl 5: 40–7
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameter Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 1028–32
   PubMed Web of Science ®Google Scholar
• Romero Y, Cameron AJ, Schaid DJ, McDonnell SK, Burgart LJ, Hardtke CL, et al. Barrett's esophagus: prevalence in relatives with and without frequent symptoms. Am J Gastroenterol 2002; 97: 1127–32
   PubMed Web of Science ®Google Scholar
• Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia as regional variations in the west. Gastroenterology 2002; 122: 588–90
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk?. Gastroenterology 1984; 87: 927–33
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000; 119: 333–8
   PubMed Web of Science ®Google Scholar
• Rogge-Wolf C, Seldenrijk CA, Das KM, Timmer R, Breumelhof R, Smout AJ, et al. Prevalence of mabDAS-1 positivity in biopsy specimens from the esophagogastric junction. Am J Gastroenterol 2002; 97: 2979–85
   PubMed Web of Science ®Google Scholar
• Carton E, Mulligan ED, Keeling PW, Tanner A, McDonald G, Reynolds JV. Specialized intestinal metaplasia: analysis of prevalence, risk factors and association with gastro-oesophageal reflux disease. Br J Surg 2000; 87: 362–73
   PubMed Web of Science ®Google Scholar
• Csendes A, Smok G, Burdiles P, Korn O, Gradiz M, Rojas J, et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus 2003; 16: 24–8
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999; 94: 937–43
   PubMed Web of Science ®Google Scholar
• Campos GM, DeMeester SR, Peters JH, Oberg S, Crookes PF, Hagen JA, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 2001; 136: 1267–73
   PubMedGoogle Scholar
• Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002; 97: 225–9
   PubMed Web of Science ®Google Scholar
• Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461–7
   PubMed Web of Science ®Google Scholar
• Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 2002; 47: 256–64
   PubMed Web of Science ®Google Scholar
• Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 2003; 58: 350–5
   PubMed Web of Science ®Google Scholar
• Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002; 97: 1930–6
   PubMed Web of Science ®Google Scholar
• Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C, et al. Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 2001; 48: 310–3
   PubMed Web of Science ®Google Scholar
• Voutilainen M, Farkkila M, Juhola M, Nuorva K, Mauranen K, Mantynen T, et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol 1999; 94: 913–8
   PubMed Web of Science ®Google Scholar
• Mabe K, Yamada M, Oguni I, Takahashi T. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 1999; 43: 1788–91
   PubMed Web of Science ®Google Scholar
• Takabayashi F, Harada N, Yamada M, Murohisa B, Oguni I. Inhibitory effect of green tea catechins in combination with sucralfate on Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol 2004; 39: 61–3
   PubMed Web of Science ®Google Scholar